SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its ...

Heartbeam AI plus VCG outperformed an expert panel of three cardiologists by 40% in detecting atrial flutter. HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Call Transcript May 12, 2024 HeartBeam ...

Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. Before we begin the ...

HeartBeam ( (BEAT)) has provided an update. HeartBeam, Inc. has appointed Robert Eno as the new CEO, effective October 21, 2024, to lead the company through commercialization and growth of its ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient ...

The 510(k) submission for the HeartBeam system continues to progress through active review by the FDA. The Company has successfully responded to the questions asked by the FDA and is currently ...

Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization Strengthening ...

The Company continues to make steady progress toward key clinical and regulatory milestones on the HeartBeam system. Branislav Vajdic, Ph.D., Founder of HeartBeam, appointed as President.